Jacek Kunicki
Overview
Explore the profile of Jacek Kunicki including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
37
Citations
183
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Kunicki J, Rzewuska N, Kunicki M, Wisniewski P
Diagnostics (Basel)
. 2023 Jan;
13(1).
PMID: 36611301
Leiomyomas are common lesions that are usually located in the genitourinary and gastrointestinal tracts. Primary leiomyomas at the skull base are uncommon. They are composed of well-differentiated smooth muscle cells...
12.
Rymuza J, Kober P, Rusetska N, Mossakowska B, Maksymowicz M, Nyc A, et al.
Cells
. 2022 Dec;
11(23).
PMID: 36497102
Acromegaly results from growth hormone hypersecretion, predominantly caused by a somatotroph pituitary neuroendocrine tumor (PitNET). Acromegaly-causing tumors are histologically diverse. Our aim was to determine transcriptomic profiles of various somatotroph...
13.
Mossakowska B, Rusetska N, Konopinski R, Kober P, Maksymowicz M, Pekul M, et al.
Cancers (Basel)
. 2022 Nov;
14(22).
PMID: 36428684
Protein deubiquitinases and are known driver genes in corticotroph pituitary neuroendocrine tumors (PitNETs). mutations have pleiotropic effects that include notable changes in genes' expression. Genes involved in cell cycle regulation...
14.
Tomasik A, Stelmachowska-Banas M, Maksymowicz M, Czajka-Oraniec I, Raczkiewicz D, Zielinski G, et al.
Front Endocrinol (Lausanne)
. 2022 Oct;
13:957301.
PMID: 36187106
Background: Transsphenoidal adenomectomy (TSS) of somatotroph pituitary neuroendocrine tumor (PitNET) is the first-line treatment of acromegaly. Pharmacological treatment is recommended if surgery is contraindicated or did not lead to disease...
15.
Mossakowska B, Kober P, Rusetska N, Boresowicz J, Maksymowicz M, Pekul M, et al.
Int J Mol Sci
. 2022 Mar;
23(5).
PMID: 35270010
Corticotroph pituitary adenomas commonly cause Cushing's disease (CD), but some of them are clinically silent. The reason why they do not cause endocrinological symptoms remains unclear. We used data from...
16.
Kunicki J, Rzewuska N, Kunicki M, Rogala P, Wagrodzki M
Pol Arch Intern Med
. 2021 Dec;
132(4).
PMID: 34935327
No abstract available.
17.
Kunicki J, Rzewuska N, Maksymowicz M, Matyja E, Grajkowska W
Pol Arch Intern Med
. 2021 Jul;
131(10).
PMID: 34213297
No abstract available.
18.
Rusetska N, Kober P, Krol S, Boresowicz J, Maksymowicz M, Kunicki J, et al.
J Clin Med
. 2021 Feb;
10(4).
PMID: 33546126
Purpose: Epigenetic dysregulation plays a role in pituitary tumor pathogenesis. Some differences in DNA methylation were observed between invasive and noninvasive nonfunctioning gonadotroph tumors. This study sought to determine the...
19.
Bujko M, Kober P, Boresowicz J, Rusetska N, Zeber-Lubecka N, Paziewska A, et al.
J Clin Med
. 2021 Jan;
10(3).
PMID: 33498176
Background: mutations are the most common driver changes in corticotroph pituitary tumors. They have direct effect on cells' proteome through disturbance of ubiquitination process and also influence gene expression. The...
20.
Boresowicz J, Kober P, Rusetska N, Maksymowicz M, Paziewska A, Dabrowska M, et al.
Int J Endocrinol
. 2020 Dec;
2020:3730657.
PMID: 33354213
Purpose: Nonfunctioning gonadotropic pituitary neuroendocrine tumors (PitNETs) are among the most frequent neoplasms of pituitary gland. Although PitNETs are commonly considered benign, a notable part of patients suffer from tumor...